ETON PHARMACEUTICALS

Eton Pharmaceuticals is a pharmaceutical company that focuses on developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eight product candidates in various stages of development. It was founded in 2017 and headquartered in Studio City, California.
ETON PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2017-01-01
Address:
Studio City, California, United States
Country:
United States
Website Url:
http://www.etonpharma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
27.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Key Employee Changes
Date | New article |
---|---|
2022-04-11 | Eton Pharmaceuticals Names James Gruber Finance Chief |
Official Site Inspections
http://www.etonpharma.com Semrush global rank: 1.42 M Semrush visits lastest month: 19.7 K
- Host name: 149.199.83.34.bc.googleusercontent.com
- IP address: 34.83.199.149
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Eton Pharmaceuticals"
Company | Eton Pharmaceuticals
At Eton, we donโt focus on a single therapeutic area or category. Instead, we provide hope by sourcing potential therapies worldwide.See details»
Eton Pharmaceuticals
A rare opportunity to change lives. Together, we can put our care, expertise, and resources to work, providing long-needed treatments to underserved populations.See details»
Eton Pharmaceuticals Announces Appointment of Jenn Adams to โฆ
DEER PARK, Ill., March 17, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing โฆSee details»
Eton Pharmaceuticals - Org Chart, Teams, Culture & Jobs - The Org
Eton Pharmaceuticals is a Deer Park, Illinois-based pharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing the U.S Food โฆSee details»
Eton Pharmaceuticals, Inc. (ETON) - Yahoo Finance Canada
See the company profile for Eton Pharmaceuticals, Inc. (ETON) including business summary, industry/sector information, number of employees, business summary, corporate governance, โฆSee details»
Eton Pharmaceuticals, Inc. (ETON) Company Profile & Facts
See the company profile for Eton Pharmaceuticals, Inc. (ETON) including business summary, industry/sector information, number of employees, business summary, corporate governance, โฆSee details»
Eton Pharmaceuticals - Crunchbase Company Profile
Eton Pharmaceuticals is a pharmaceutical company that focuses on developing and commercializing pharmaceutical products to fulfill an unmet patient need.See details»
Eton Pharmaceuticals | LinkedIn
Eton Pharmaceuticals is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases.See details»
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2020 ...
DEER PARK, Ill., March 04, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing โฆSee details»
Eton Pharmaceuticals - Craft
Oct 29, 2024 Eton Pharmaceuticals has 1 employees at their 1 location and $31.64 m in annual revenue in FY 2023. See insights on Eton Pharmaceuticals including office locations, โฆSee details»
Eton Pharmaceuticals to Report First Quarter 2024 Financial โฆ
DEER PARK, Ill., April 29, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (โEtonโ or the "Companyโ) (Nasdaq: ETON), an innovative pharmaceutical company focused on โฆSee details»
Mission | Eton Pharmaceuticals
21925 W. Field Pkwy #235 Deer Park, IL 60010 (847) 787-7361See details»
Eton Pharmaceuticals Announces Acquisition of FDA-Approved
Sep 13, 2022 Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral SolutionSee details»
Eton Pharmaceuticals Advances Its Commitment to Rare
15 hours ago Adds an additional commercial and strategic rare disease product to Etonโs portfolio; Galzin is FDA-approved for the treatment of the ultra-rare metabolic condition of โฆSee details»
News Release Details - ir.etonpharma.com
Mar 7, 2023 In addition, the Company receives royalties on three FDA-approved products and is entitled to receive milestone payments on other products. For more information, please visit โฆSee details»
Business Model | Eton Pharmaceuticals
We strive to develop our therapies, file for FDA approval, and launch them with unprecedented speed. Below are a few examples of the types of value Eton tries to unlock:See details»
Eton Pharmaceuticals Advances Its Commitment to Rare Disease โฆ
1 day ago Adds an additional commercial and strategic rare disease product to Etonโs portfolio; Galzin is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson DiseaseSee details»
Partnerships | Eton Pharmaceuticals
Successfully identifying high-potential therapies . Efficiently executing clinical studies. Gaining timely regulatory approval. Establishing a robust chain to support seamless product access โฆSee details»
Eton Pharmaceuticals Acquires Galzin® to Enhance Rare Disease
15 hours ago Eton Pharmaceuticals acquires FDA-approved Galzin for Wilson Disease, enhancing its rare disease treatment portfolio and patient support services.See details»
Eton Pharmaceuticals to Report Second Quarter 2022 Financial โฆ
DEER PARK, Ill., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing โฆSee details»